Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106835

Simultaneous Measurement of Thyroxine and Triiodothyronine Peripheral Turnover Kinetics in Man

John T. Nicoloff, James C. Low, Jean H. Dussault, and Delbert A. Fisher

Department of Medicine, University of Southern California School of Medicine, University of California at Los Angeles School of Medicine, and the Los Angeles County University of Southern California Medical Center, Los Angeles, California 90033

Find articles by Nicoloff, J. in: PubMed | Google Scholar

Department of Medicine, University of Southern California School of Medicine, University of California at Los Angeles School of Medicine, and the Los Angeles County University of Southern California Medical Center, Los Angeles, California 90033

Find articles by Low, J. in: PubMed | Google Scholar

Department of Medicine, University of Southern California School of Medicine, University of California at Los Angeles School of Medicine, and the Los Angeles County University of Southern California Medical Center, Los Angeles, California 90033

Find articles by Dussault, J. in: PubMed | Google Scholar

Department of Medicine, University of Southern California School of Medicine, University of California at Los Angeles School of Medicine, and the Los Angeles County University of Southern California Medical Center, Los Angeles, California 90033

Find articles by Fisher, D. in: PubMed | Google Scholar

Published March 1, 1972 - More info

Published in Volume 51, Issue 3 on March 1, 1972
J Clin Invest. 1972;51(3):473–483. https://doi.org/10.1172/JCI106835.
© 1972 The American Society for Clinical Investigation
Published March 1, 1972 - Version history
View PDF
Abstract

Serum triiodothyronine (T3) kinetics in man have been difficult to define presumably due to the interference of iodoproteins generated during the peripheral metabolism of T3. The use, in the present study, of an anion-column chromatographic method for separation of serum T3 as well as thyroxine (T4) from these iodoproteins has overcome this technical handicap. Simultaneous measurement of serum 125I-T3 and 131I-T4 kinetics were performed in 31 subjects from the clinical categories of euthyroid, primary hypothyroid, thyrotoxic and posttreatment hypothyroid Graves' disease, factitial thyrotoxic, and idiopathically high and low thyroxinebinding globulin states. The normal mean T3 fractional turnover rate (kT3) was 0.68 (half-life = 1.0 days), increased in toxic Graves' disease patients to 1.10 (half-life = 0.63 days), and decreased in primary hypothyroid patients to 0.50 (half-life = 1.38 days). The mean T3 equilibration time averaged 22 hr except in hypothyroid and high thyroxine-binding globulin (TBG) patients where the equilibration period was delayed by 10 hr. The mean T3 distribution space in normal subjects was 38.4 liters. This was reduced in subjects with high TBG levels (26 liters) and increased in patients with low TBG and in all hyperthyroid states (53-55 liters). The normal serum T3 concentration was estimated by radioimmunoassay to be 0.106 μg/100 ml. Combined with the mean T3 clearance value of 26.1 liters/day, the calculated T3 production rate was 27.6 μg/day. The mean T3 production rate increased to 201 μg/day in thyrotoxic Graves' disease patients and was reduced to 7.6 μg/day in primary hypothyroid subjects. T3 production rate was normal in subjects with altered TBG states. The ratio of T3 to T4 production rate in normal subjects was 0.31 and was unchanged in patients with altered TBG values. This ratio was increased in all Graves' disease patients with the highest value being 0.81 in the posttreatment hypothyroid Graves' disease group. This apparent preferential production of T3 may have been responsible for the retention of rapid turnover kinetics for T3 and T4 observed in treated Graves' disease patients. The finding that factitial thyrotoxic patients also displayed similar rapid T3 and T4 turnover kinetics indicates that these alterations are not a unique feature of Graves' disease per se. When comparing the peripheral turnover values for T3 and T4 in man, it is apparent that alterations in metabolic status and serum TBG concentration influence both hormones in a parallel manner; however, changes in metabolic status seem to have a greater influence on T3 kinetics while alterations in TBG concentrations have a greater effect on T4. These observations probably relate to the differences in TBG binding affinity and peripheral tissue distribution of these two hormones.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 473
page 473
icon of scanned page 474
page 474
icon of scanned page 475
page 475
icon of scanned page 476
page 476
icon of scanned page 477
page 477
icon of scanned page 478
page 478
icon of scanned page 479
page 479
icon of scanned page 480
page 480
icon of scanned page 481
page 481
icon of scanned page 482
page 482
icon of scanned page 483
page 483
Version history
  • Version 1 (March 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts